Refine your search
-
Authors
-
Item types
-
Topics
- *Diabetes Mellitus, Type 2/dt [Drug Therapy]
- *Diabetes Mellitus/dt [Drug Therapy]
- *Glucagon-Like Peptide-1 Receptor/ag [Agonists]
- *Hypoglycemic Agents/tu [Therapeutic Use]
- *Insulin, Long-Acting/tu [Therapeutic Use]
- *Liraglutide/tu [Therapeutic Use]
- Aged
- Clinical Trials, Phase III as Topic
- Drug Combinations
- Female
- Glucagon-Like Peptide 1/aa [Analogs & Derivatives]
- Glucagon-Like Peptide 1/tu [Therapeutic Use]
- Glucagon-Like Peptides/aa [Analogs & Derivatives]
- Glucagon-Like Peptides/tu [Therapeutic Use]
- Humans
- Immunoglobulin Fc Fragments/tu [Therapeutic Use]
- Insulin Glargine/tu [Therapeutic Use]
- Liraglutide/tu [Therapeutic Use]
- Male
- Treatment Outcome
- Show more
- Show less
-
Collections
-
Languages